Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617552 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
A Phase 2 study, sponsored by Tranzyme.
- Completed
- Registry status
- Phase 2
- Development phase
- 267
- Enrollment target
NCT00617552 is a Phase 2 study that has completed, run by Tranzyme. The registered enrollment target is 267 participants.
The verdict
NCT00617552, a Phase 2 study, has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 267 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether TZP-101 is effective in the management of post operative ileus in subjects undergoing major open abdominal surgery (i.e. partial large bowel resection).
Interventions
- DRUG 5% dextrose in water
- DRUG TZP-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00617552
The ClinicalTrials.gov registry entry for NCT00617552 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tranzyme, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5% dextrose in water is the first listed.
NCT00617552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00617552 about?
NCT00617552 is a clinical study titled "Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery". The purpose of this study is to determine whether TZP-101 is effective in the management of post operative ileus in subjects undergoing major open abdominal surgery (i.e. partial large bowel resection).
What is the current status of trial NCT00617552?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 267 participants. The study started on 2007-07. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00617552?
The interventions under investigation include: 5% dextrose in water (DRUG), TZP-101 (DRUG).
Who is sponsoring clinical trial NCT00617552?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.